INO Therapeutics' Merger

INO Therapeutics raised a round of funding on February 22, 2007. Investors include Ikaria.

INO Therapeutics manufactures and markets pharmaceutical drugs and devices for the treatment of hypoxic respiratory failure in newborns. The company provides pharmaceutical products under the INOmax b…

Articles about INO Therapeutics' Merger: